Valeo Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-100
Closed -$107K 841
2025
Q4
$107K Hold
100
﹤0.01% 789
2025
Q3
$76.3K Hold
100
﹤0.01% 800
2025
Q2
$14.9K Hold
100
﹤0.01% 774
2025
Q1
$82.6K Sell
100
-700
-88% -$582K ﹤0.01% 665
2024
Q4
$485K Buy
800
+700
+700% +$580K 0.01% 416
2024
Q3
$88.6K Buy
+100
New +$89.9K ﹤0.01% 677
2024
Q2
Sell
-4,000
Closed -$2.93K 703
2024
Q1
$2.93K Buy
4,000
+3,400
+567% +$2.42M ﹤0.01% 649
2023
Q4
$350 Buy
+600
New +$350K ﹤0.01% 641

Other funds holding LLY

Valeo Financial Advisors's LLY Position: Q2 2026 in Review

Valeo Financial Advisors reduced its Eli Lilly (LLY) stake by 1.1% in Q2 2026, selling an estimated $1.43M and leaving 130,247 shares worth $156M. The position accounts for 3.3% of the portfolio, ranked #7.

Valeo Financial Advisors first reported a position in LLY in Q3 2017 and has held it in 36 quarters since. 1,122 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Valeo Financial Advisors held 130,247 shares of Eli Lilly worth $156M as of Q2 2026.
  • Valeo Financial Advisors sold 1,398 Eli Lilly shares in Q2 2026, an estimated $1.43M.
  • Eli Lilly made up 3.3% of Valeo Financial Advisors's portfolio in Q2 2026, its #7 holding.
  • Valeo Financial Advisors first reported a position in Eli Lilly in Q3 2017 and has held it in 36 quarters since.
  • 1,122 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Valeo Financial Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.